期刊文献+

基因芯片筛选应力性骨折差异表达基因 被引量:1

Screening and identification of differential expression genes related to stress fracture by cDNA microarry assay
原文传递
导出
摘要 目的 了解应力性骨折(SF)患者与正常人群相比较的外周血差异表达基因.方法 选取入伍新兵(均为男性),采用1:1配比的病例对照研究,正常对照组与SF组各3例.收集被测试者空腹肘静脉血提取RNA,纯化后进行人表达谱芯片试验.SAM软件分析芯片结果.选取表达差异最显著并有提示意义的差异基因,应用实时定量聚合酶链反应(PCR)技术进行验证.结果 SF组上调基因21条,下调基因1条.表达差异最显著的基因为TNFRSF10C,其验证结果显示,SF组TNFRSF10C的相对表达量与正常对照组相比较,3组上调,1组下调.结论 SF患者与正常人群外周血之间存在基因表达差异,SF的发生发展是一个涉及多种功能基因表达的复杂的生物学过程,为SF的生物力学研究提供了背景资料,并未其早期诊断和筛查提供了重要线索. Objective To evaluate the differentially expressed genes between the stress fracture (SF) cases and controls. Methods Total RNA was extracted and purified from peripheral blood sample of 3 SF analysis. The hybridization data were analyzed using SAM software. Parts of these genes were analyzed and identified by real-time PCR. Results Upregulated and downregulated genes were 22 and 1, respectively. Thus the highest ratio and most significant cytokine was tumor necrosis factor receptor superfamily, member 10c (TNFRSF10C). The result of real-time PCR showed that TNFRSF10C was over-expressed in 3 cases and lowexpressed in 1 case. Conclusion Obvious difference exists in gene expression between SF cases and controls,showing there may be a lot of genes involving in the occurrence and development of SF. Meanwhile, the identification of the specific genes is helpful for biomechanics study, early diagnosis and screening of SF.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2010年第11期827-830,共4页 Chinese Journal of Industrial Hygiene and Occupational Diseases
关键词 骨折 应力性 基因 DNA 互补 Fractures, stress Genes DNA, complementery
  • 相关文献

参考文献4

二级参考文献138

  • 1李祖国,李良寿,李远贵,邓敬兰,张世忠,程卫青,姚祖生,陈友绩.新兵基础训练期间应力性骨折的发生率和分布特征[J].第四军医大学学报,1993,14(2):112-115. 被引量:16
  • 2黄昌林,王炳南,黄涛,韩西,钟汉馨,李祖国,张莉,黄咏梅.骨应力性塑形改建的研究及其对新兵基础训练的指导意义[J].解放军医学杂志,1994,19(3):194-198. 被引量:31
  • 3李国平,高崇玄.德国外伤药“疼痛平”临床疗效观察[J].中国运动医学杂志,1995,14(2):100-104. 被引量:2
  • 4李祖国,黄昌林,李良寿,李远贵,邓敬兰,陈友绩.应力性骨折的诊断试验评价[J].中华骨科杂志,1996,16(4):241-244. 被引量:8
  • 5曹来宾.易误诊为骨肿瘤的骨关节病变[J].实用放射科学杂志,1987,3(1):38-39.
  • 6[1]Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-90.
  • 7[2]Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3:673-82.
  • 8[3]Wajant H, Moosmayer D, Wuest T, et al. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene 2001; 20:4101-6.
  • 9[4]Tecchio C, Huber V, Scapini P, et al. IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood 2004;103:3837-44
  • 10[5]Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science 1997; 276:111-3.

共引文献36

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部